AKT1 and neural tube defect: In our study, we found that the mRNA of Akt and Bcl-2 was increased in the DADLE treatment group (IRD vs. NTD; 2.03 ± 0.58 vs. 0.79 ± 0.32, p = 0.0136) (Figure 5A).